Alignment Healthcare Target of Unusually Large Options Trading (NASDAQ:ALHC)

Alignment Healthcare, Inc. (NASDAQ:ALHC) was the target of some unusual options trading on Tuesday. Investors purchased 19,456 call options on the stock. This represents an increase of approximately 996% compared to the average daily volume of 1,775 call options.

Insider Activity

In other news, EVP Joseph Konowiecki sold 25,000 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total value of $600,000.00. Following the sale, the executive vice president directly owned 1,103,816 shares in the company, valued at approximately $26,491,584. This represents a 2.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Kao sold 385,270 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $12.68, for a total value of $4,885,223.60. Following the sale, the chief executive officer directly owned 1,223,473 shares of the company’s stock, valued at $15,513,637.64. This represents a 23.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 1,353,977 shares of company stock valued at $20,263,764. 5.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Alignment Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Allworth Financial LP grew its position in Alignment Healthcare by 8.9% during the 4th quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock worth $137,000 after purchasing an additional 566 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Alignment Healthcare by 9.2% in the first quarter. PNC Financial Services Group Inc. now owns 11,445 shares of the company’s stock worth $202,000 after buying an additional 962 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Alignment Healthcare by 46.6% during the second quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock worth $80,000 after buying an additional 1,070 shares during the period. Versant Capital Management Inc lifted its stake in shares of Alignment Healthcare by 463.3% during the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock worth $33,000 after buying an additional 1,135 shares during the period. Finally, Nykredit A S purchased a new stake in shares of Alignment Healthcare during the second quarter valued at $36,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Stock Performance

ALHC stock opened at $8.71 on Thursday. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. The business has a 50-day moving average price of $15.44 and a 200 day moving average price of $17.82. The company has a market capitalization of $1.81 billion, a P/E ratio of 45.84 and a beta of 1.11. Alignment Healthcare has a 1-year low of $8.52 and a 1-year high of $25.12.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. The company had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.31 billion. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The firm’s quarterly revenue was up 31.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.07 EPS. As a group, equities research analysts forecast that Alignment Healthcare will post 0.17 EPS for the current fiscal year.

Analyst Ratings Changes

ALHC has been the subject of several research analyst reports. Raymond James Financial downgraded Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and decreased their target price for the stock from $22.00 to $19.00 in a research report on Monday, August 3rd. Barclays reduced their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. TD Cowen reiterated a “buy” rating on shares of Alignment Healthcare in a report on Wednesday. Finally, Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Seven equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $23.60.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Unusual options activity showed investors purchasing 19,456 call options—roughly 996% above typical volume—suggesting some traders are positioning for a rebound, although this is speculative and does not confirm improving fundamentals.
• Positive Sentiment: Brokerages continue to give ALHC an overall “Moderate Buy” rating, indicating that some analysts view the sharp decline as potentially excessive. Alignment Healthcare Given Moderate Buy Recommendation
• Neutral Sentiment: CEO John Kao sold 27,400 shares for approximately $356,200 under a pre-arranged Rule 10b5-1 trading plan. The planned nature of the sale reduces its significance as a bearish signal, though his direct ownership declined by 4.43%. SEC Insider Sale Filing
• Negative Sentiment: Investors reacted sharply to comments at the Baird conference, including management’s apparent reluctance to discuss star ratings. Because star ratings can affect Medicare Advantage payments and member enrollment, the lack of visibility increased concerns about Alignment’s outlook. Alignment Falls After Baird Investor Conference
• Negative Sentiment: Coverage highlighted potential Medicare Advantage reform and uncertainty over how new rule changes could affect Alignment’s economics, adding to pressure on the shares. Medicare Advantage Rule Changes
• Negative Sentiment: Several law firms announced or updated investigations into possible securities-law violations following the stock’s steep conference-related decline. These announcements do not establish wrongdoing, but they add reputational and potential litigation risk. Hagens Berman Investigation Update

Alignment Healthcare Company Profile

Alignment Healthcare, Inc is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.

The company combines health-plan operations with proprietary technology intended to support personalized care.